statistiche ricercatore

Continente	#
NA - Nord America	540
EU - Europa	291
AS - Asia	200
SA - Sud America	42
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	5
OC - Oceania	1
Totale	1.101

Nazione	#
US - Stati Uniti d'America	523
RU - Federazione Russa	116
SG - Singapore	90
IT - Italia	48
BR - Brasile	37
DE - Germania	32
IE - Irlanda	32
CN - Cina	28
VN - Vietnam	27
HK - Hong Kong	22
FI - Finlandia	20
CA - Canada	12
FR - Francia	12
NL - Olanda	8
GB - Regno Unito	6
CZ - Repubblica Ceca	4
ID - Indonesia	4
IN - India	4
TR - Turchia	4
MY - Malesia	3
UZ - Uzbekistan	3
AE - Emirati Arabi Uniti	2
BD - Bangladesh	2
DZ - Algeria	2
ES - Italia	2
IQ - Iraq	2
JP - Giappone	2
MX - Messico	2
PL - Polonia	2
RO - Romania	2
TN - Tunisia	2
AR - Argentina	1
AT - Austria	1
AU - Australia	1
BE - Belgio	1
CH - Svizzera	1
CO - Colombia	1
CW - ???statistics.table.value.countryCode.CW???	1
DK - Danimarca	1
GP - Guadalupe	1
GY - Guiana	1
JM - Giamaica	1
JO - Giordania	1
KR - Corea	1
LT - Lituania	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PH - Filippine	1
SA - Arabia Saudita	1
SE - Svezia	1
SY - Repubblica araba siriana	1
UA - Ucraina	1
UY - Uruguay	1
VE - Venezuela	1
ZA - Sudafrica	1
Totale	1.080

Nome	#
Cyclic and acyclic amine oxide alkyl derivatives as potential adjuvants in antimicrobial chemotherapy against methicillin-resistant staphylococcus aureus with an MDR profile	178
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators	141
Quatsomes Formulated with l-Prolinol-Derived Surfactants as Antibacterial Nanocarriers of (+)-Usnic Acid with Antioxidant Activity	132
Structurally Related Liposomes Containing N-Oxide Surfactants: Physicochemical Properties and Evaluation of Antimicrobial Activity in Combination with Therapeutically Available Antibiotics	123
Mechanism of non-competitive inhibition of the SARS-CoV-2 3CL protease dimerization: Therapeutic and clinical promise of the lichen secondary metabolite perlatolinic acid	122
Influence of Lipid Composition on Physicochemical and Antibacterial Properties of Vancomycin-Loaded Nanoscale Liposomes	115
New and simplified method for drug combination studies by checkerboard assay	112
Natural compounds as potential inhibitors of viral 3-chymotrypsin-like protease (3CLpro)	93
Evaluation of the Biolabo Turbidimetric Assay for Automated Determination of Haemoglobin A1c	46
Future research perspectives on energy metabolism and mood disorders: a brief narrative review on metabolic status, mitochondrial hypothesis and potential biomarkers	39
Totale	1.101

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	14	0	0	0	0	0	0	2	2	0	0	0	10
2022/2023	84	7	5	3	10	5	6	2	6	36	2	2	0
2023/2024	48	4	2	3	2	2	15	0	1	0	1	3	15
2024/2025	241	4	2	16	16	15	18	47	22	30	22	31	18
2025/2026	570	24	64	72	58	38	31	70	15	58	111	26	3
2026/2027	144	14	18	28	84	0	0	0	0	0	0	0	0
Totale													1.101